Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysis
Crossref DOI link: https://doi.org/10.1007/s10549-016-4040-4
Published Online: 2016-11-02
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jankowski, Clémentine http://orcid.org/0000-0002-0152-8101
Guiu, S.
Cortet, M.
Charon-Barra, C.
Desmoulins, I.
Lorgis, V.
Arnould, L.
Fumoleau, P.
Coudert, B.
Rouzier, R.
Coutant, C.
Reyal, F.
License valid from 2016-11-02